What is Biohaven Ltd Quarterly Revenue?

Biohaven Ltd Quarterly Revenue Biohaven Ltd Dec-2024 Quarterly Revenue is $0 Million which is growth of 0% YoY.

What is Biohaven Ltd Quarterly Net Profit?

Biohaven Ltd Quarterly Net Profit Biohaven Ltd Dec-2024 Quarterly Net Profit is $-187 Million which is growth of -29.1% YoY.

What is Biohaven Ltd Annual Revenue?

Biohaven Ltd Annual Revenue Biohaven Ltd Annual Revenue is $0 Million which is growth of 0% YoY.

What is Biohaven Ltd Annual Net Profit?

Biohaven Ltd Annual Net Profit Biohaven Ltd Annual Net Profit is $-846 Million which is growth of -107.4% YoY.

What is Biohaven Ltd Total Shareholders Fund?

Biohaven Ltd Total Shareholders Fund Biohaven Ltd Dec-2024 Total Shareholders Fund is $423 Million which is growth of -1.1% YoY.

What is Biohaven Ltd Total Assets?

Biohaven Ltd Total Assets Biohaven Ltd Dec-2024 Total Assets is $615 Million which is growth of 19.9% YoY.

What is Biohaven Ltd Book Value Per Share?

Biohaven Ltd Book Value Per Share Biohaven Ltd Book Value Per Share is $4 which is growth of 16.0% YoY.

What is Biohaven Ltd ROE?

Biohaven Ltd ROE Biohaven Ltd ROE is -199% which is growth of 114.4% YoY.

What is Biohaven Ltd Cash From Operating Activity?

Biohaven Ltd Cash From Operating Activity Biohaven Ltd Cash From Operating Activity is $-582 Million which is growth of -75.6% YoY.

What is Biohaven Ltd Net Cash Flow?

Biohaven Ltd Net Cash Flow Biohaven Ltd Net Cash Flow is $-150 Million which is growth of -1594.6% YoY.

What is Biohaven Ltd Annual Net Profit?

Biohaven Ltd Annual Net Profit fell 107.37% in the last year to $846.42 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

What is Biohaven Ltd Price to Earning Ratio?

Biohaven Ltd Price to Earning Ratio is -2.46, which is negative.

What is Biohaven Ltd Stock Price?

Biohaven Ltd Stock Price fell 47.76% and underperformed its sector by 55.09% in the past year.

What is Biohaven Ltd Quarterly Net profit?

Biohaven Ltd Quarterly Net profit fell 29.07% YoY to $186.84 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

What is Biohaven Ltd Debt to Equity Ratio?

Biohaven Ltd Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Biohaven Ltd Return on Equity(ROE)?

Biohaven Ltd Return on Equity(ROE) for the last financial year was -198.83%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Biohaven Ltd Mutual Fund Holding?

Biohaven Ltd Mutual Fund Holding decreased by 1.64% in the last quarter to 57.2.

What is Biohaven Ltd Institutional Holding?

Biohaven Ltd Institutional Holding increased by 0.01% in the last quarter to 90.73.

How is the Biohaven Ltd today?

The Biohaven Ltd today is trading in the green, up by 9.05% at 20.37.

How has Biohaven Ltd performed historically?

The Biohaven Ltd is currently trading up 9.05% on an intraday basis in the past week the index rose 15.61%. The index has been down -45.81% in the past quarter and fell -47.76% in the past year. You can view this in the overview section.

Biohaven Ltd XNYS: BHVN

Biohaven Ltd Live Share Price Today, Share Analysis and Chart

Name: Biohaven Ltd: Is Infosys Ltd. worth buying?
Item: Biohaven Ltd
Rating: 0.74950
Author: Trendlyne DVM scores

Download real time

20.37 1.69 (9.05%)

63.35% Fall from 52W High

2.1M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Biohaven Ltd is on 30 Apr 2025 for the purpose of Biohaven Ltd Annual General Meeting for 2025 See details

Biohaven Ltd Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	2,079.1
PE TTM Negative PE TTM Unavailable in chosen country	-2.5
Price to Book Below industry Median Unavailable in chosen country	4.9
Institutional holding current Qtr % High in industry Unavailable in chosen country	90.7
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-29.1
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-107.4
Piotroski Score Below industry Median Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-44.9
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-198.8
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-150

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

3.5 / 100

Technically Bearish

26.5 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Biohaven Ltd Stock Price Analysis

Day Price Range 9.0% 1 Day return Unavailable in chosen country	20.4 (LTP) 18.520.5 LowHigh
Week Price Range 15.6% 1 Week return Unavailable in chosen country	20.4 (LTP) 17.520.5 LowHigh
Month Price Range -29.2% 1 Month return Unavailable in chosen country	20.4 (LTP) 15.831.2 LowHigh
52 Week Price Range -47.8% 1 Year return Unavailable in chosen country	20.4 (LTP) 15.855.6 LowHigh

View full Share Price History

Biohaven Ltd Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Biohaven Ltd Stock Analysis

Biohaven Ltd stock analysis with key metrics, changes, and trends.

Biohaven Ltd Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$846.42 M	107.37%	negative	Annual Net Profit fell 107.37% in the last year to $846.42 M. Its sector's average net profit growth for the last fiscal year was -30.36%.
Price to Earning Ratio	-2.46	-	negative	Price to Earning Ratio is -2.46, which is negative.
Stock Price	$20.37	-47.76%	negative	Stock Price fell 47.76% and underperformed its sector by 55.09% in the past year.
Quarterly Net profit	$186.84 M	29.07%	negative	Quarterly Net profit fell 29.07% YoY to $186.84 M. Its sector's average net profit growth YoY for the quarter was -48.37%.
Debt to Equity Ratio	0.09	-	positive	Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-198.83 %	-198.83%	negative	Return on Equity(ROE) for the last financial year was -198.83%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	57.20 %	-1.64%	negative	Mutual Fund Holding decreased by 1.64% in the last quarter to 57.2.
Institutional Holding	90.73 %	0.01%	positive	Institutional Holding increased by 0.01% in the last quarter to 90.73.

VIEW LESS

Loading data..

Biohaven Ltd - Company Profile

What does Biohaven Ltd do?

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

2024

Gross Remuneration

Year

Biohaven Ltd Live Share Price Today, Share Analysis and Chart

63.35% Fall from 52W High

Biohaven Ltd Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Biohaven Ltd Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Biohaven Ltd Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Biohaven Ltd Stock Analysis

Biohaven Ltd stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 107.37% in the last year to $846.42 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio is -2.46, which is negative.

Stock Price fell 47.76% and underperformed its sector by 55.09% in the past year.

Quarterly Net profit fell 29.07% YoY to $186.84 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -198.83%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.64% in the last quarter to 57.2.

Institutional Holding increased by 0.01% in the last quarter to 90.73.

Biohaven Ltd - Company Profile

What does Biohaven Ltd do?

Biohaven Ltd Management structure

Dr. Vlad Coric, M.D.

Chief Executive Officer and Chairman of the Board

Mr. Matthew Buten

Chief Financial Officer

Mr. Bruce Car

Chief Scientific Officer

Ms. Kimberly Gentile

Senior Vice President, Clinical Operations

Mr. George C. Clark

Chief Accounting Officer and Vice President

Biohaven Ltd Board of directors

Mr. Michael T. Heffernan, R.Ph.

Lead Independent Director

Ms. Julia P. Gregory

Independent Director

Mr. Robert J. Hugin

Independent Director

Mr. John W. Childs

Independent Director

Dr. Gregory Hugh Bailey, M.D.

Independent Director

Dr. Irina Antonijevic, M.D.,PhD

Independent Director

Biohaven Ltd FAQ

How is Biohaven Ltd today?

Biohaven Ltd today is trading in the green, and is up by 9.05% at 20.37.

How has Biohaven Ltd performed historically?

Biohaven Ltd is currently trading up 9.05% on an intraday basis. In the past week the stock rose 15.61%. stock has been down -45.81% in the past quarter and fell -47.76% in the past year. You can view this in the overview section.